Serial measurements of pharmacokinetics, DCE-MRI, blood flow, PET and biomarkers in serum/plasma--what is a useful tool in clinical studies of anti-angiogenic drugs?

International journal of clinical pharmacology and therapeutics

Volumn 40, Issue 12, 2002, Pages 573-574

  Mross, K ^a   Fuxius, S ^a   Drevs, J ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; BIOLOGICAL MARKER;

AREA UNDER THE CURVE; ARTICLE; BLOOD FLOW; CAPILLARY PERMEABILITY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 1 CLINICAL TRIAL;

ANGIOGENESIS INHIBITORS; AREA UNDER CURVE; BIOLOGICAL MARKERS; CAPILLARY PERMEABILITY; CLINICAL TRIALS, PHASE I; HUMANS; MAGNETIC RESONANCE IMAGING; REGIONAL BLOOD FLOW; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0142088389     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP40573     Document Type: Article

References (0)